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http://dx.doi.org/10.1016/j.kjms.201
1607-551X/Copyright ª 2014, KaohsiuAbstract Emerging evidence suggests that activation of the Notch1 signaling pathway
inducing epithelial to mesenchymal transition (EMT) mediated by Snail/Slug promotes invasion
and metastasis of breast cancer cells in vitro. However, the implication of the Notch1-Snail/
Slug-EMT axis in breast cancer patients remains unclear. A total of 200 formalin-fixed
paraffin-embedded samples of invasive ductal carcinoma (IDC), and 37 adjacent non-
neoplastic tissue (ANNT) samples from patients who had not been treated with neoadjuvant
therapy were examined. Expression of Notch1, Slug, Snail, E-cadherin, N-cadherin, and vimen-
tin was determined by immunohistochemistry on tissue microarrays (TMAs). The correlation
between protein expression and clinicopathological characteristics of breast cancer patients
was also evaluated. Results showed that a significantly high percentage of cases with high
expression of Notch1 (74%, 148/200), Slug (36%, 72/200), Snail (62%, 124/200), and N-cadherin
(77%, 153/200) and a low percentage of cases with high expression of E-cadherin (27%, 54/200)
were observed in IDC compared to those in ANNTs. High Notch1, Slug, Snail, and N-cadherin
expression and low E-cadherin expression in patients with IDC were significantly correlated
with lymph node metastasis. In addition, correlation analysis results revealed that high Notch1
expression was significantly associated with high Slug, Snail, and N-cadherin expression and
low E-cadherin expression in IDC. Furthermore, a high Snail expression was significantly asso-
ciated with low E-cadherin expression, and a high Slug expression was found to be significantly
associated with increased N-cadherin expression in patients with IDC. Hence, our studyeclare no conflicts of interest.
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Notch1-Snail/Slug-EMT and breast cancer 71suggested that the Notch1-Snail/Slug-EMT axis may be implicated in the lymph node metastasis
affecting patients with IDC.
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Epithelial to mesenchymal transition (EMT) is a funda-
mental process governing morphogenesis, characterized by
the loss of E-cadherin and a concurrent increase in N-cad-
herin and/or vimentin expression [1]. During EMT, epithelial
cells, undergoing phenotypic transition to mesenchymal
cells, lose their apicalebasal polarity, disrupt intercellular
adhesive junctions, degrade basement membrane compo-
nents, and acquire migratory and invasive behaviors [2]. In
breast cancer patients, cancer cells undergoing EMT are
easy to invade and shift [3] and therefore, contribute to
breast cancer-related deaths [4]. EMT may be induced by a
variety of molecules and mechanisms [5].
The expression levels of Snail and Slug, two known tran-
scriptional factors, are frequently elevated in breast cancer
tissue, and may initiate the EMT process by suppression of E-
cadherin expression [3]. Additionally, several studies on
breast cancer have reported that aberrant expression of Slug
and Snail is associated with unfavorable clinicopathological
parameters and poor patient outcome [6,7]. Slug/Snail-
mediated EMT has been linked to several signaling path-
ways, such as Notch1, Transforming growth factor-b
(TGF-b), and Wnt signaling [8].
The Notch1 signaling pathway is implicated in develop-
mental and metastatic EMT [9]. Elevated expression of
Notch1 has been considered as an indicator of human
mammary tumorigenesis [10]. The observation that Notch1
pathway activation is required for EMT, via Snail tran-
scriptional induction, was first made during the study of
cardiac valve and cushion formation in heart development
[11]. Furthermore, previous in vitro studies in breast can-
cer cell lines revealed a possible mechanism of Notch-
induced EMT in breast cancer metastasis, in which Notch,
in complex with the transcription factor, C promoter
binding factor-1/Suppressor of Hairless/Lag-1 (CSL),
directly induces the expression of Slug or Snail, which
subsequently decreases E-cadherin expression and en-
hances the mesenchymal phenotype; this results in
increased invasiveness [12,13]. Studies have also revealed
that hypoxia-induced activation of Notch1 could result in
increased expression of Slug and Snail and decreased
expression of E-cadherin. Conversely, Notch1 pathway in-
hibition abrogated the hypoxia-mediated increase in Slug
and Snail expression, resulting in decreased migration and
invasion of cultured breast cancer cells [14]. Moreover, a
previous study has suggested that Jagged1-mediated Notch
activation facilitates EMT in breast cancer cells by repres-
sing the expression of E-cadherin, and promoting tumor
growth, metastasis, and inhibition of anoikis, in vitro and in
xenograft models [12]. Although the mechanism of Notch1-
induced EMT in metastasis and invasion of breast cancercells has been demonstrated in vitro, it remains uncon-
firmed in primary human breast cancer tissues.
The present study aimed to elucidate the clinicopatho-
logical importance of Notch1 and EMT biomarkers in breast
cancer by examining 200 invasive ductal carcinoma (IDC) and
37 adjacent non-neoplastic tissue (ANNT) samples using tissue
microarray (TMA)-based immunohistochemical (IHC) analysis.
Materials and methods
Patients and tissue samples
Surgically resected specimens from 200 cases of primary IDC
that had not been treated with neoadjuvant therapy, and 37
ANNT samples, were obtained between 2000 and 2010 from
the Pathology Department of the First Affiliated Hospital,
Shihezi University, School of Medicine, China. The study was
approved by the Institutional Human Ethics Committee of
Shihezi University School of Medicine, and informed consent
was obtained from all patients enrolled in the study. Age at
diagnosis, tumor-node-metastasis (TNM) stage, and lymph
node status were recorded. All of the tumors were histo-
logically classified and graded by two independent patholo-
gists, based on the World Health Organization criteria and
the Sixth Edition of the TNM Classification of the Interna-
tional Union against Cancer. Estrogen receptor (ER) status
was determined using IHC. Progesterone receptor and
human epidermal growth factor 2 (HER2) status were
determined as previously reported [9]. Clinicopathological
characteristics are summarized in Table 1.
TMAs and immunohistochemistry
TMAs were constructed using tumor tissue from 200 cases
and adjacent normal tissue from 37 cases as described
previously. TMA sections were cut from paraffin blocks,
dewaxed in xylene, rehydrated in a graded alcohol series,
and subjected to antigen retrieval. Endogenous peroxi-
dase activity was blocked by immersion in 3% hydrogen
peroxide for 10 minutes. Sections were then washed in
phosphate-buffered saline (PBS) twice for 5 minutes.
Positive and negative controls for each antibody were
used according to the manufacturers’ instructions. TMA
sections were incubated at 4C overnight with primary
antibodies. After washing with PBS, sections were incu-
bated with secondary antibody (Dako Cytomation EnVision
System; Dako, Glostrup, Denmark) for 30 minutes, washed
twice for 5 minutes in PBS, and visualized using 3,3-dia-
minobenzidine (DAB) (Dako). Finally, the sections were
counterstained with hematoxylin, dehydrated using
graded alcohol, and subsequently coverslipped. Table 2
Table 1 Associations between protein expression of Notch1, Slug, Snail, and epithelial to mesenchymal transition (EMT)
markers and clinicopathological factors in breast carcinoma.
Factors Notch1 E-cadherin N-cadherin Vimentin Slug Snail
High
(n)
Low
(n)
High
(n)
Low
(n)
High
(n)
Low
(n)
High
(n)
Low
(n)
High
(n)
Low
(n)
High
(n)
Low
(n)
Age (y)
 51 (n Z 118) 85 33 33 85 91 27 8 110 41 77 78 40
> 51 (n Z 82) 63 19 21 61 62 20 8 74 31 51 46 36
Histological grade
Ⅰ and Ⅱ (n Z 136) 102 34 43* 93* 98* 38* 10 126 43** 93** 80 56
Ⅲ (n Z 64) 46 18 11* 53* 55* 9* 6 58 29** 25** 44 20
LN metastasis
Positive (n Z 89) 73* 16* 17* 72* 74* 15* 4 85 39* 50* 64* 25*
Negative (n Z 111) 75* 36* 37* 74* 79* 32* 12 99 33* 78* 60* 51*
TNM stage
Ⅰ and Ⅱ (n Z 171) 124 47 48 123 129 42 15 156 57 114 100* 71*
Ⅲ and Ⅳ (n Z 29) 24 5 6 23 24 5 1 28 15 14 24* 5*
ER status
Negative (n Z 94) 70 24 27 67 72 22 10 84 41* 53* 58 36
Positive (n Z 106) 78 28 27 79 81 25 6 100 31* 75* 66 40
PR status
Negative (n Z 95) 69 26 27 68 72 23 10 85 38 57 55 40
Positive (n Z 105) 79 26 27 78 81 24 6 99 34 71 69 36
HER2 status
Negative (n Z 54) 39 15 16 38 45 9 4 50 20 34 32 22
Positive (n Z 146) 109 37 38 108 108 38 12 134 52 94 92 54
ER Z estrogen receptor; HER2 Z human epidermal growth factor receptor 2; LN Z lymph node; PR Z progesterone receptor;
TNM Z tumor-node-metastasis.
*p < 0.05.
**p < 0.01.
72 Y.-W. Cao et al.shows detailed technical characteristics of the different
primary antibodies used, including the commercial
source, working dilution, antigen-retrieval method, anti-
body clone, and subcellular location.
Scoring criteria for IHC staining
IHC staining was independently analyzed by two in-
vestigators who were blinded to clinical data and patient
outcome. Discordant results were reviewed to achieve
agreement with the use of a five-headed microscope.
Notch1, E-cadherin, N-cadherin, and vimentin expressionTable 2 Primary antibodies used in immunohistochemical analy
Antibody Clone Dilution Source
Notch1 Rabbit pAb 1:200 Sigmaa Microwave
Slug Rabbit pAb 1:50 Abcamb Microwave
Snail Goat pAb 1:50 Abcamb Microwave
E-cadherin Mouse mAb 1:400 Dakoc Autoclave
N-cadherin Rabbit pAb 1:400 Abcamb Autoclave
Vimentin Mouse mAb 1:800 Dakoc Autoclave
mAb Z monoclonal antibody; pAb Z polyclonal antibody.
a Sigma-Aldrich, St. Louis, MO, USA.
b Abcam, Cambridge, UK.
c Dako, Glostrup, Denmark.were semiquantitatively scored according to the criteria of
Wu et al. [15] and Prasad et al. [16] with slight modifica-
tions as follows: IHC staining was scored according to in-
tensity (0, negative; 1, weak; 2, moderate; and 3, strong),
and percentage of positively stained tumor cells (1e25%,
1þ; 26e50%, 2þ; 51e75%, 3þ; and > 76%, 4þ) and a final
score was obtained by multiplying the two scores. A score
of 0e3 was considered low expression, and a score of 4e12
was considered high expression. The following criteria were
used to score the expression of Slug and Snail: (), no
detectable staining; (þ), < 10%; (þþ), 10e50%; and
(þþþ), > 50% of tumor cells staining positive. Nuclearsis.
Pretreatment Subcellular location
with sodium citrate buffer Cytoplasm
with sodium citrate buffer Nucleus
with EDTA Nucleus
with sodium citrate buffer Cell membrane
with sodium citrate buffer Cell membrane or cytoplasm
with sodium citrate buffer Cytoplasm
Notch1-Snail/Slug-EMT and breast cancer 73immunoreactivity in > 10% of tumor cells was regarded as
high expression.
Statistical analysis
All of the statistical analyses were performed using SPSS
17.0 (SPSS Inc., Chicago, IL, USA). Chi-square tests were
performed to determine the difference in protein expres-
sion between IDC and ANNT samples. The association be-
tween clinicopathological characteristics and protein
expression was also determined. Furthermore, correlations
between expression levels of the different protein markers
were determined. A p value < 0.05 from a 2-tailed test was
considered significant.
Results
Expression of Notch1, Slug, Snail, and markers of
EMT in invasive ductal carcinoma
The expression of Notch1, Slug, Snail, and the EMT markers,
E-cadherin, N-cadherin, and vimentin in 200 primary IDC
specimens was analyzed using IHC. Notch1 and vimentin
showed a cytoplasmic staining pattern, Slug and Snail
showed nuclear expression, E-cadherin showed membra-
nous expression, and N-cadherin displayed a membranous
and/or cytoplasmic staining pattern (Figs. 1 and 2). Analysis
of IHC results showed that high expression of Notch1 was
detected at a significantly higher frequency in IDC than in
ANNT samples (p < 0.001). High expression of Slug, Snail,
and N-cadherin was also associated with IDC samples
(p Z 0.003, p Z 0.033, and p Z 0.030, respectively).
Overexpression of E-cadherin was significantly decreased in
tumor samples compared to non-neoplastic samples
(p < 0.001). However, no significant difference was
observed in the expression of vimentin between IDC and
ANNT samples.Figure 1. Significantly increased Notch1, Slug, Snail, and N-ca
observed in infiltrating ductal carcinoma (IDC) compared to adjaceCorrelation between the expression of Notch1,
Slug, Snail, and EMT markers, and the
clinicopathological characteristics of infiltrating
ductal carcinoma
The association between the expression of Notch1, Slug,
Snail, and EMT markers, and the clinicopathological pa-
rameters of IDC are summarized in Table 1. Our results
showed that high expression of Notch1, Slug, Snail, and N-
cadherin, and low expression of E-cadherin were signifi-
cantly associated with lymph node metastasis (p Z 0.021,
pZ 0.039, pZ 0.01, pZ 0.024, pZ 0.047, respectively).
In addition, high expression of Slug was found to be asso-
ciated with a higher tumor grade (p Z 0.005) and negative
ER status (p Z 0.035). High Snail expression was signifi-
cantly associated with a higher tumor stage (p Z 0.013).
Moreover, high N-cadherin expression and low E-cadherin
expression were associated with a higher tumor grade
(p Z 0.031 and p Z 0.032, respectively). No significant
associations were observed between the expression of
Notch1, Slug, Snail, and EMT markers, and other clinico-
pathological characteristics, such as age, progesterone re-
ceptor, and HER2 status.
Associations between Notch1, Slug, Snail, and EMT
markers in infiltrating ductal carcinoma
To investigate whether Notch1 expression is associated with
EMT in IDC, we examined the association between Notch1
expression and EMT markers using IHC analysis. The results
showed that high Notch1 expression was significantly
correlated with low E-cadherin expression (p < 0.001) and
high N-cadherin expression (p Z 0.010). An inverse corre-
lation was found between E-cadherin and N-cadherin
expression (p Z 0.004). To determine whether Slug and
Snail play a role in Notch1-induced EMT, the associations
between Notch1, Slug, Snail, and EMT markers weredherin high expression, and low E-cadherin expression, were
nt non-neoplastic tissue (ANNT) samples.
Figure 2. Immunohistochemical staining of differentially expressed proteins in infiltrating ductal carcinoma (IDC) and adjacent
non-neoplastic tissue (ANNT). (A) Strong cytoplasmic expression of Notch1 in IDC (original magnification, 400 ); (B) strong nuclear
expression of Snail in IDC (original magnification, 400 ); (C) low membranous expression of E-cadherin in IDC (original magnifi-
cation, 400 ); (D) strong membranous and cytoplasmic expression of N-cadherin in IDC (original magnification, 400 ); (E) low
expression of Notch1 in ANNT (original magnification, 400 ); (F) low expression of Snail in ANNT (original magnification, 400 ); (G)
strong expression of E-cadherin in ANNT (original magnification, 400 ); (H) low membranous or cytoplasmic expression of
N-cadherin in ANNT (original magnification, 400 ).
74 Y.-W. Cao et al.analyzed. The results showed a statistically significant
correlation between the overexpression of Notch1 and high
expression of Slug and Snail (p Z 0.005 and p < 0.001,
respectively). In addition, a significant inverse correlation
was observed between Snail expression and E-cadherin
expression (p Z 0.014), and high expression of Slug was
significantly correlated with high N-cadherin expression
(p Z 0.040). Detailed results are shown in Table 3.Discussion
In this study, we assessed the expression of Notch1, Snail,
Slug, and EMT markers in primary IDC and ANNT samples
using IHC.
Studies in animal models have implicated mammary-
specific overexpression of a constitutively active truncated
form of Notch1 breast tumor development. Data from
studies in humans have further revealed that activation of
the Notch1 signaling pathway is increased in breast cancerTable 3 Relationships between Notch1, Slug, Snail, and epithe
cinoma tissue.
EMT markers Cases (n) Notch1 p E-cadhe
High (n) Low (n) High (n) Lo
Slug (high) 72 61 11 0.005 19
Slug (low) 128 87 41 35
Snail (high) 124 107 17 < 0.001 26
Snail (low) 76 41 35 28
E-cadherin (high) 54 28 26 < 0.001
E-cadherin (low) 146 120 26
N-cadherin (high) 153 120 33 0.010 34
N-cadherin (low) 47 28 19 20
Vimentin (high) 16 12 4 > 0.99 4
Vimentin (low) 184 135 48 50
High Z high immunohistochemical (IHC) expression; low Z low IHC eand that expression of Notch1 is correlated with enhanced
metastasis and poor survival [10,17,18]. We found a
significantly higher frequency of Notch1 overexpression in
IDC patients with lymph node metastasis than in those
without lymph node metastasis. This result is consistent
with findings from previous studies that suggest that over-
expression of Notch1 may be involved in the acquisition of
an invasive and metastatic phenotype. In recent years,
accumulating evidence has indicated that activation of
Notch1 induces EMT [19]. Leong et al. [12] reported that
activated Notch1 upregulates Slug to promote cancer pro-
gression by facilitating EMT-induced cancer cell metastasis,
and they also demonstrated a positive correlation between
Notch1 and Slug expression in human breast cancer cell
lines. Chen et al. [14] found that the hypoxia-mediated
activation of Notch1 increased the expression of Slug and
Snail and decreased the expression of E-cadherin in vitro,
resulting in enhanced invasiveness of breast cancer cells.
Consistent with these findings, our results indicated that
the overexpression of Notch1 statistically correlated withlial to mesenchymal transition (EMT) markers in breast car-
rin p N-cadherin p Vimentin p
w (n) High (n) Low (n) High (n) Low (n)
53 0.884 61 11 0.040 7 65 0.501
93 92 36 9 119
98 0.014 96 28 0.695 11 113 0.562
48 57 19 5 71
119 0.006
27
12 > 0.99 10 6 0.285
134 143 41
xpression.
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expression of E-cadherin.
The activity of Snail and Slug can inhibit the interaction
between adherens and tight junctions, reducing intercel-
lular adhesion and facilitating invasion and metastasis in
various types of cancer [20,21]. Previous studies have re-
ported that Snail or Slug expression in breast cancer is
related to poor outcome and lymph node metastasis [22].
Vincent-Salomon and Thiery [23] demonstrated a link be-
tween progression of IDC and altered expression of
adhesion-related factors, such as decreased E-cadherin and
increased N-cadherin expression, which are involved in
Snail/Slug-induced EMT. In agreement with the results of
previous studies, we found that overexpression of Slug and
Snail was significantly associated with lymph node metas-
tasis. In addition, overexpression of Slug was associated
with a higher tumor grade and negative ER status, and
overexpression of Snail was significantly associated with a
higher tumor stage. On the basis of our findings and those of
previous studies [13,16], we speculate that overexpression
of Slug and Snail may accelerate the progression of IDC via
EMT. The negative association found between Snail and
E-cadherin expression, and the positive association seen
between Slug and N-cadherin expression in the current
study also support this hypothesis.
Numerous studies have indicated a role for EMT in pro-
moting invasion and dissemination of epithelial malignant
cells, including those of breast carcinoma [24]. In this
study, we observed that low expression of E-cadherin was
significantly correlated with lymph node metastasis and
higher tumor grade, while overexpression of N-cadherin
was associated with a higher tumor grade and positive
status of lymph node. The loss of E-cadherin with concur-
rent increase in N-cadherin expression is one of the hall-
marks of EMT, and a frequently reported phenomenon in
breast cancer progression [25,26]. In this study, we found
that low E-cadherin expression was significantly associated
with overexpression of N-cadherin, suggesting the occur-
rence of EMT in IDC. Surprisingly, we found no significant
association between vimentin expression and lymph node
metastasis or higher tumor grade, which may suggest that
vimentin has a limited role in EMT-associated metastasis in
certain tumors. Consistent with these results, two previous
studies also found a lack of association between vimentin
expression and lymph node metastasis in aggressive sub-
types of breast cancer, such as triple-negative and basal-
like breast cancer [27,28].
In conclusion, we found that overexpression of Notch1
was significantly associated with high Slug, Snail, and
N-cadherin expression and low E-cadherin expression. In
addition, we found that Snail overexpression was signifi-
cantly associated with low E-cadherin expression; likewise,
overexpression of Slug was significantly correlated with
N-cadherin, suggesting the importance of Notch1 in initi-
ating Snail/Slug-mediated regulation of EMT. An inverse
correlation was found between E-cadherin and N-cadherin
expression, indicating the occurrence of EMT in IDC.
Although several in vitro studies have proposed a possible
mechanism of breast cancer metastasis involving the
Notch1-Snail/Slug-EMTaxis, very few studies have examined
this mechanism in human tissue. Our analysis of Notch1,
Snail, Slug, and EMT marker expression patterns revealedthat the Notch1-Snail/Slug-EMT axis was associated with
lymph node metastasis in breast cancer. However, we were
unable to analyze the association of the Notch1-Snail/Slug-
EMT axis with patient prognosis, as survival data for these
breast carcinoma patients was unavailable. The association
of the Notch1-Snail/Slug-EMT axis with clinical outcomes in
breast cancer should be addressed in future studies.
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